Disease | anxiety disorder |
Phenotype | C0041696|major depressive disorder |
Sentences | 8 |
PubMedID- 21208594 | Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder. |
PubMedID- 23945451 | Omega-3 polyunsaturated fatty acid (pufa) status in major depressive disorder with comorbid anxiety disorders. |
PubMedID- 26461261 | The most frequent psychiatric comorbidity was social anxiety disorder with major depressive disorder (n = 100; 54.1% of the comorbid cases). |
PubMedID- 25097285 | Aim: selective serotonin reuptake inhibitors (ssri) and serotonin-norepinephrine reuptake inhibitors (snri) are effective in treating anxiety disorders associated with major depressive disorder (mdd). |
PubMedID- 26247218 | Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder. |
PubMedID- 22303519 | The search terms were bipolar disorder and major depressive disorder, cross-referenced with anxiety disorders/symptoms, panic disorder, agoraphobia, generalized anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. |
PubMedID- 22126712 | A large number of studies agree that anxiety disorders occur in patients with major depressive disorder (mdd) far more frequently than expected by chance (kessler et al.1996; gorwood, 2004). |
PubMedID- 23487258 | Conclusions and relevance: the most common diagnosis in screen-positive women was major depressive disorder with comorbid generalized anxiety disorder. |
Page: 1